Cargando…

Expression of the inhibitory receptor NKG2A correlates with increased liver and splenic NK cell response to activating receptor engagement

INTRODUCTION: Natural killer (NK) cells play a critical role in the innate immune response to viruses and tumors, and comprise a large proportion of the hepatic lymphocyte population. They must remain tolerant to non‐pathogenic antigens while protecting the host from harmful agents. Herein, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer, Claire E., Key, Phillip N., Zhu, Toby, Shabsovich, Mark, Ni, Ann, Tripathy, Sandeep K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418142/ https://www.ncbi.nlm.nih.gov/pubmed/28474506 http://dx.doi.org/10.1002/iid3.156

Ejemplares similares

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
por: Koch, Christine, et al.
Publicado: (2017)

Chronic Ly49H Receptor Engagement in vivo Decreases NK Cell Response to Stimulation Through ITAM-Dependent and Independent Pathways Both in vitro and in vivo
por: Key, Phillip N., et al.
Publicado: (2019)

The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice
por: Shreeve, Norman, et al.
Publicado: (2021)

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
por: Jelenčić, Vedrana, et al.
Publicado: (2018)

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
por: Myers, Jacob A., et al.
Publicado: (2022)

Inhibitory NKG2A(+) and absent activating NKG2C(+) NK cell responses are associated with the development of EBV(+) lymphomas
por: Vietzen, Hannes, et al.
Publicado: (2023)

Continuous engagement of a self-specific activation receptor induces NK cell tolerance
por: Tripathy, Sandeep K., et al.
Publicado: (2008)

Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
por: Molfetta, Rosa, et al.
Publicado: (2017)

Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya
por: Thanapati, Subrat, et al.
Publicado: (2017)

Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor
por: Dubois, Sigrid, et al.
Publicado: (2020)

NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
por: Brooks, Andrew G., et al.
Publicado: (1997)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
por: Riese, Peggy, et al.
Publicado: (2020)

Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I
por: Koike, Junzo, et al.
Publicado: (2004)

Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NKG2D
por: Denaeghel, Sofie, et al.
Publicado: (2021)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
por: Zingoni, Alessandra, et al.
Publicado: (2013)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

Dynamic Shift from CD85j/ILT-2 to NKG2D NK Receptor Expression Pattern on Human Decidual NK during the First Trimester of Pregnancy
por: Marlin, Romain, et al.
Publicado: (2012)

Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma
por: Xu, Yuanji, et al.
Publicado: (2018)

NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells
por: Babic, Marina, et al.
Publicado: (2020)

Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts
por: Picardi, Alessandra, et al.
Publicado: (2015)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation
por: García-Cuesta, Eva María, et al.
Publicado: (2015)

Recruitment of Activation Receptors at Inhibitory NK Cell Immune Synapses
por: Schleinitz, Nicolas, et al.
Publicado: (2008)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)

Macrophages Help NK Cells to Attack Tumor Cells by Stimulatory NKG2D Ligand but Protect Themselves from NK Killing by Inhibitory Ligand Qa-1
por: Zhou, Zhixia, et al.
Publicado: (2012)

Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients()
por: Nieto-Velázquez, Nayeli Goreti, et al.
Publicado: (2016)

Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8(+) T cells
por: Chen, Xiangyu, et al.
Publicado: (2022)

Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D
por: Gröschel, Carina, et al.
Publicado: (2017)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
por: Alfarra, Helmi, et al.
Publicado: (2020)

Differential Expression of NK Receptors CD94 and NKG2A by T Cells in Rheumatoid Arthritis Patients in Remission Compared to Active Disease
por: Walsh, Ceara E., et al.
Publicado: (2011)

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection
por: Wang, Yadong, et al.
Publicado: (2017)

Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
por: González-Foruria, Iñaki, et al.
Publicado: (2015)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
por: Whalen, Kerry A., et al.
Publicado: (2023)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
por: Béziat, Vivien, et al.
Publicado: (2015)

NKG2A is a NK cell exhaustion checkpoint for HCV persistence
por: Zhang, Chao, et al.
Publicado: (2019)

High Metabolic Function and Resilience of NKG2A-Educated NK Cells
por: Highton, Andrew J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_822vra3a22u54dign474hapme3